BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24502199)

  • 1. Genotyping of BCL11A and HBS1L-MYB SNPs associated with fetal haemoglobin levels: a SNaPshot minisequencing approach.
    Fanis P; Kousiappa I; Phylactides M; Kleanthous M
    BMC Genomics; 2014 Feb; 15():108. PubMed ID: 24502199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of variants at BCL11A and HBS1L-MYB with hemoglobin F and hospitalization rates among sickle cell patients in Cameroon.
    Wonkam A; Ngo Bitoungui VJ; Vorster AA; Ramesar R; Cooper RS; Tayo B; Lettre G; Ngogang J
    PLoS One; 2014; 9(3):e92506. PubMed ID: 24667352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between BCL11A, HSB1L-MYB, and XmnI γG-158 (C/T) gene polymorphism and hemoglobin F level in Egyptian sickle cell disease patients.
    El-Ghamrawy M; Yassa ME; Tousson AMS; El-Hady MA; Mikhaeil E; Mohamed NB; Khorshied MM
    Ann Hematol; 2020 Oct; 99(10):2279-2288. PubMed ID: 32772141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective BCL11A and HBS1L-MYB polymorphisms in a cohort of 102 Congolese patients suffering from sickle cell anemia.
    Mikobi TM; Tshilobo Lukusa P; Aloni MN; Lumaka AZ; Kaba DK; Devriendt K; Matthijs G; Mbuyi Muamba JM; Race V
    J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28332727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variants at BCL11A and HBS1L-MYB loci Influence Hb F Levels in Chinese Zhuang β-Thalassemia Intermedia Patients.
    Lai Y; Chen Y; Chen B; Zheng H; Yi S; Li G; Wei H; He S; Zheng C
    Hemoglobin; 2016 Nov; 40(6):405-410. PubMed ID: 28361591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphic variations influencing fetal hemoglobin levels: association study in beta-thalassemia carriers and in normal individuals of Portuguese origin.
    Pereira C; Relvas L; Bento C; Abade A; Ribeiro ML; Manco L
    Blood Cells Mol Dis; 2015 Apr; 54(4):315-20. PubMed ID: 25842369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
    Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
    Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of single nucleotide polymorphisms in the BCL11A and HBS1L-MYB gene on the HbF levels and clinical severity of sickle cell anaemia patients.
    Upadhye D; Jain D; Trivedi Y; Nadkarni A; Ghosh K; Colah R
    Ann Hematol; 2016 Jun; 95(7):1201-3. PubMed ID: 27098811
    [No Abstract]   [Full Text] [Related]  

  • 10. HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers.
    Stadhouders R; Aktuna S; Thongjuea S; Aghajanirefah A; Pourfarzad F; van Ijcken W; Lenhard B; Rooks H; Best S; Menzel S; Grosveld F; Thein SL; Soler E
    J Clin Invest; 2014 Apr; 124(4):1699-710. PubMed ID: 24614105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 12. Foetal haemoglobin elevation, unfavourable prognosis, and protective role of genetic variants
    Borrayo-LóPez FJ; Ibarra-Cortés B; Perea-Díaz F; MuñOz-Zúñiga AI; Montoya-Fuentes H; Soto-Padilla JM; Rizo-De La Torre LDC
    J Genet; 2024; 103():. PubMed ID: 38736250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotype.
    Ngo D; Bae H; Steinberg MH; Sebastiani P; Solovieff N; Baldwin CT; Melista E; Safaya S; Farrer LA; Al-Suliman AM; Albuali WH; Al Bagshi MH; Naserullah Z; Akinsheye I; Gallagher P; Luo HY; Chui DH; Farrell JJ; Al-Ali AK; Alsultan A
    Blood Cells Mol Dis; 2013 Jun; 51(1):22-6. PubMed ID: 23465615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
    Ojewunmi OO; Adeyemo TA; Oyetunji AI; Inyang B; Akinrindoye A; Mkumbe BS; Gardner K; Rooks H; Brewin J; Patel H; Lee SH; Chung R; Rashkin S; Kang G; Chianumba R; Sangeda R; Mwita L; Isa H; Agumadu UN; Ekong R; Faruk JA; Jamoh BY; Adebiyi NM; Umar IA; Hassan A; Grace C; Goel A; Inusa BPD; Falchi M; Nkya S; Makani J; Ahmad HR; Nnodu O; Strouboulis J; Menzel S
    Hum Mol Genet; 2024 May; 33(10):919-929. PubMed ID: 38339995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients.
    Razak SAA; Murad NAA; Masra F; Chong DLS; Abdullah N; Jalil N; Alauddin H; Sabudin RZAR; Ithnin A; Khai LC; Aziz NA; Muda Z; Ibrahim H; Latiff ZA
    Curr Mol Med; 2018; 18(5):295-305. PubMed ID: 30289070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism at BCL11A compared to HBS1L-MYB loci explains less of the variance in HbF in patients with sickle cell disease in Cameroon.
    Bitoungui VJ; Ngogang J; Wonkam A
    Blood Cells Mol Dis; 2015 Mar; 54(3):268-9. PubMed ID: 25488618
    [No Abstract]   [Full Text] [Related]  

  • 18. The XmnI (G)gamma polymorphism influences hemoglobin F synthesis contrary to BCL11A and HBS1L-MYB SNPs in a cohort of 57 beta-thalassemia intermedia patients.
    Nguyen TK; Joly P; Bardel C; Moulsma M; Bonello-Palot N; Francina A
    Blood Cells Mol Dis; 2010 Aug; 45(2):124-7. PubMed ID: 20472475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional polymorphisms of BCL11A and HBS1L-MYB genes affect both fetal hemoglobin level and clinical outcomes in a cohort of children with sickle cell anemia.
    Sales RR; Belisário AR; Faria G; Mendes F; Luizon MR; Viana MB
    Ann Hematol; 2020 Jul; 99(7):1453-1463. PubMed ID: 32447424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fetal hemoglobin regulating genetic variants identified in homozygous (HbSS) and heterozygous (HbSA) subjects from South Mexico.
    Rizo-de la Torre LC; Borrayo-López FJ; Perea-Díaz FJ; Aquino E; Venegas M; Hernández-Carbajal C; Espinoza-Mata LL; Ibarra-Cortés B
    J Trop Pediatr; 2022 Aug; 68(5):. PubMed ID: 36130307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.